Chad L. Barber

Molecular Biology · 2007

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Chad L. Barber trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Rakesh K. Jain
  2. J. Folkman

Papers from Chad L. Barber's perspective

Ordered by how strongly the researchers Chad L. Barber trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy (Nature Medicine)
  2. Opinion: Angiogenesis: an organizing principle for drug discovery? (Nature reviews. Drug discovery)
  3. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. (Journal of Clinical Investigation)
  4. VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. (American Journal of Physiology. Heart and Circulatory Physiology)
  5. Angiogenesis in life, disease and medicine (Nature)
  6. Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. (American Journal of Pathology)
  7. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis (Nature Cell Biology)
  8. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. (Journal of Clinical Oncology)
  9. Sorafenib in advanced clear-cell renal-cell carcinoma. (New England Journal of Medicine)
  10. Clinical translation of angiogenesis inhibitors (Nature Reviews. Cancer)

Their papers